trifluoperazine
Selected indexed studies
- Trifluoperazine for schizophrenia. (Cochrane Database Syst Rev, 2004) [PMID:14974020]
- Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia. (Cochrane Database Syst Rev, 2014) [PMID:25003310]
- Trifluoperazine overdosage. (Practitioner, 1967) [PMID:6044122]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Trifluoperazine for schizophrenia. (2004) pubmed
- Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia. (2014) pubmed
- Trifluoperazine overdosage. (1967) pubmed
- Trifluoperazine activates AMPK / mTOR / ULK1 signaling pathway to induce mitophagy in osteosarcoma cells. (2024) pubmed
- Trifluoperazine: A Sprightly Old Drug. (2016) pubmed
- Trifluoperazine blocks the human cardiac sodium channel, Na(v)1.5, independent of calmodulin. (2016) pubmed
- Trifluoperazine inhibits Sendai virus-induced hemolysis. (1986) pubmed
- Phenelzine and trifluoperazine poisoning. (1965) pubmed
- Trifluoperazine and foetal abnormalities. (1963) pubmed
- [Trifluoperazine in organ-neuroses]. (1968) pubmed